University of Utah Health

New Kind of CRISPR Could Treat Viral Infection and Cancer by Shredding Sick Cells’ DNA

When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.

CRISPR Therapeutics proved the strength of its technology a couple of years ago when it won approval for its first product.
European Medical Journal

CRISPR Gene Therapy Shows Promise in Sickle Cell Disease

CRISPR gene therapy increases haemoglobin and fetal haemoglobin in sickle cell disease, reducing vaso occlusive events in ...

CRISPR Breakthrough Brings First In-Body Cure With Lonvo-Z

A CRISPR Therapy Just Cured A Disease From Inside The Body For The First Time. The Gene-Editing Era Officially Started Monday ...

CRISPR genome editing and the future of Down syndrome treatment

Deaf children can now hear thanks to a new treatment that repairs a defective gene. Researchers associated with the biotech ...
Fierce Biotech

Intellia races in vivo CRISPR therapy to FDA after phase 3 data paint ‘compelling’ picture

A phase 3 trial of Intellia Therapeutics’ in vivo gene-editing therapy lonvoguran ziclumeran (lonvo-z) has hit its primary ...
Labroots

First Personalized CRISPR Therapy Given to Infant Patient

In a major breakthrough, a patient has been treated with a personalized CRISPR therapeutic that aims to cure their rare genetic disease. This individual, who is known as KJ, was diagnosed with severe ...
Hosted on MSN

First CRISPR patient spurs push for wider rare disease access

A year after Baby KJ became the first person to receive a personalized CRISPR base-editing therapy for a lethal genetic disorder, he is thriving and has avoided a liver transplant. His case, enabled ...

Intellia seeks FDA approval for in vivo CRISPR therapy

The company's treatment for hereditary angioedema reduced attacks by 87% vs. placebo in a Phase 3 trial, clearing the way for ...
inforum

First CRISPR patient cured of sickle cell speaks in Fargo

Victoria Gray, the first person cured of sickle cell using CRISPR gene editing therapies, spoke in Fargo about her journey and the need to lower the $2M treatment cost. Victoria Gray, cured of sickle ...

A new kind of CRISPR could treat viral infection and cancer by shredding sick cells' DNA

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...